13F
← All fund report cards

Bellevue Group AG

13F equity value
$4.2B
Positions
155
Top 10 concentration
41.9%
Quarters / total new picks
32 / 324
13F equity value over time
$0M$5B$10B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.3% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = -0.69, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
-2.0%
t-stat
-0.69
Quarterly win rate
50%
Annualized excess
-3.4%
$1 → follow vs universe
$1.62 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.95520180630: follow 0.73320180930: follow 0.78520181231: follow 0.77020190331: follow 0.73920190630: follow 0.75620190930: follow 0.90820191231: follow 0.92420200331: follow 1.01020200630: follow 0.98720200930: follow 1.02520201231: follow 0.92220210331: follow 0.95420210630: follow 1.11920210930: follow 0.89020211231: follow 0.75820220331: follow 0.83420220630: follow 0.82520220930: follow 0.83320221231: follow 0.89420230331: follow 1.12820230630: follow 0.93820230930: follow 1.33220231231: follow 1.36320240331: follow 1.45920240630: follow 1.68320240930: follow 1.77220241231: follow 1.70520250331: follow 1.56520250630: follow 1.53320250930: follow 1.55520251231: follow 1.622 0.67 1.46 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 155 · 2026 Q1

Ticker Value Weight QoQ
VRTX $304M
7.2%
HOLD
ARGX $229M
5.4%
TRIM
REGN $215M
5.1%
ADD
SRRK $176M
4.2%
TRIM
GILD $163M
3.9%
ADD
RVMD $150M
3.6%
TRIM
IONS $137M
3.3%
TRIM
ISRG $132M
3.1%
TRIM
VRDN $132M
3.1%
ADD
KRYS $124M
3.0%
ADD
CRNX $119M
2.8%
ADD
ABT $118M
2.8%
TRIM
NUVL $108M
2.6%
HOLD
AMGN $104M
2.5%
ADD
BSX $92M
2.2%
TRIM
ELVN $91M
2.2%
NEW
IMCR $84M
2.0%
HOLD
MDT $83M
2.0%
ADD
ALNY $78M
1.8%
TRIM
RLAY $78M
1.8%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.